Pingda Ren

6.2k total citations · 2 hit papers
49 papers, 3.2k citations indexed

About

Pingda Ren is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Pingda Ren has authored 49 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 24 papers in Molecular Biology and 8 papers in Inorganic Chemistry. Recurrent topics in Pingda Ren's work include PI3K/AKT/mTOR signaling in cancer (12 papers), Asymmetric Hydrogenation and Catalysis (8 papers) and Cyclopropane Reaction Mechanisms (6 papers). Pingda Ren is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (12 papers), Asymmetric Hydrogenation and Catalysis (8 papers) and Cyclopropane Reaction Mechanisms (6 papers). Pingda Ren collaborates with scholars based in United States, China and United Kingdom. Pingda Ren's co-authors include Matthew R. Janes, Christian Rommel, Michael Martin, Yi Liu, Huw M. L. Davies, Kevan M. Shokat, Katti Jessen, Lian‐Sheng Li, Shunyou Wang and Morris E. Feldman and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Pingda Ren

48 papers receiving 3.1k citations

Hit Papers

The translational landsca... 2012 2026 2016 2021 2012 2016 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pingda Ren 2.3k 636 570 307 291 49 3.2k
Alexander R. Shoemaker 2.2k 1.0× 332 0.5× 906 1.6× 257 0.8× 336 1.2× 22 3.0k
Stephen K. Tahir 2.4k 1.0× 331 0.5× 980 1.7× 344 1.1× 391 1.3× 35 3.3k
Judy Lucas 2.2k 1.0× 1.1k 1.7× 1000 1.8× 480 1.6× 318 1.1× 69 4.1k
Steven A. Middleton 1.8k 0.8× 798 1.3× 1.2k 2.2× 203 0.7× 351 1.2× 63 3.7k
Jennifer L. Stamos 2.2k 1.0× 566 0.9× 788 1.4× 131 0.4× 149 0.5× 17 3.3k
Swee Y. Sharp 2.0k 0.9× 417 0.7× 750 1.3× 149 0.5× 287 1.0× 45 2.8k
Paul Nimmer 1.8k 0.8× 222 0.3× 665 1.2× 274 0.9× 315 1.1× 11 2.4k
Matthew R. Janes 2.2k 1.0× 163 0.3× 594 1.0× 247 0.8× 285 1.0× 26 2.7k
Steven W. Elmore 3.2k 1.4× 716 1.1× 1.2k 2.1× 470 1.5× 623 2.1× 37 4.8k
Angelika M. Burger 2.7k 1.2× 491 0.8× 981 1.7× 104 0.3× 297 1.0× 81 4.1k

Countries citing papers authored by Pingda Ren

Since Specialization
Citations

This map shows the geographic impact of Pingda Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingda Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingda Ren more than expected).

Fields of papers citing papers by Pingda Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingda Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingda Ren. The network helps show where Pingda Ren may publish in the future.

Co-authorship network of co-authors of Pingda Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Pingda Ren. A scholar is included among the top collaborators of Pingda Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingda Ren. Pingda Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Xiaoke, Ren Chen, Peiqiong Chen, et al.. (2025). NHC-ligated gold nanoparticles derived from cluster precursors for carbon monoxide oxidation reactions. Dalton Transactions. 54(16). 6373–6378.
2.
Ren, Pingda, Yu Ouyang, Sheng Luo, et al.. (2025). Metal powder atomization preparation, modification, and reuse for additive manufacturing: A review. Progress in Materials Science. 152. 101449–101449. 14 indexed citations
3.
Deng, Xiaohu, Pingda Ren, Yi Wang, et al.. (2021). From Lab Formulation Development to CTM Manufacturing of KO-947 Injectable Drug Products: a Case Study and Lessons Learned. AAPS PharmSciTech. 22(5). 168–168. 3 indexed citations
4.
Hansen, Rasmus, Ulf Peters, Anjali Babbar, et al.. (2018). The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors. Nature Structural & Molecular Biology. 25(6). 454–462. 100 indexed citations
5.
Patricelli, Matthew P., Matthew R. Janes, Lian‐Sheng Li, et al.. (2016). Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. Cancer Discovery. 6(3). 316–329. 530 indexed citations breakdown →
6.
Hsieh, Andrew C., Yi Liu, Nicholas T. Ingolia, et al.. (2012). The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 485(7396). 55–61. 978 indexed citations breakdown →
7.
Bartók, Beatrix, David L. Boyle, Yi Liu, et al.. (2012). PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis. American Journal Of Pathology. 180(5). 1906–1916. 87 indexed citations
8.
Janes, Matthew R., Sharmila Mallya, Jose J. Limon, et al.. (2012). Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia. 27(3). 586–594. 85 indexed citations
9.
So, Lomon, Sung Su Yea, Jean Oak, et al.. (2012). Selective Inhibition of Phosphoinositide 3-Kinase p110α Preserves Lymphocyte Function*. Journal of Biological Chemistry. 288(8). 5718–5731. 59 indexed citations
10.
Berndt, Alex, Simon Miller, Olusegun Williams, et al.. (2010). The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nature Chemical Biology. 6(2). 117–124. 215 indexed citations
11.
Janes, Matthew R., Jose J. Limon, Lomon So, et al.. (2010). Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nature Medicine. 16(2). 205–213. 276 indexed citations
12.
Zhang, Guobao, Pingda Ren, Nathanael S. Gray, et al.. (2009). Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II. Bioorganic & Medicinal Chemistry Letters. 19(23). 6691–6695. 5 indexed citations
13.
Zhang, Guobao, Pingda Ren, Nathanael S. Gray, et al.. (2008). Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I. Bioorganic & Medicinal Chemistry Letters. 18(20). 5618–5621. 26 indexed citations
14.
Barun, Okram, A. S. Nagle, Francisco Adrián, et al.. (2006). A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors. Chemistry & Biology. 13(7). 779–786. 124 indexed citations
15.
Luesch, Hendrik, Tom Wu, Pingda Ren, et al.. (2005). A Genome-Wide Overexpression Screen in Yeast for Small-Molecule Target Identification. Chemistry & Biology. 12(1). 55–63. 84 indexed citations
16.
Davies, Huw M. L., Pingda Ren, Norman Kong, Tammy Sexton, & Steven R. Childers. (2002). Synthesis of iodinated 3β-aryltropanes with selective binding to either the dopamine or serotonin transporters. Bioorganic & Medicinal Chemistry Letters. 12(6). 845–847. 4 indexed citations
17.
Davies, Huw M. L., Pingda Ren, Norman Kong, Tammy Sexton, & Steven R. Childers. (2001). Synthesis and monoamine transporter affinity of 3β-(4-(2-pyrrolyl)phenyl)-8-azabicyclo[3.2.1]octanes and 3β-(5-Indolyl)-8-azabicyclo[3.2.1]octanes. Bioorganic & Medicinal Chemistry Letters. 11(4). 487–489. 6 indexed citations
18.
Ren, Pingda, et al.. (1997). Highly Erythro-Selective 2-Cyclohexenylation of Aldehydes Promoted by Active Metal Bismuth from NaBH4 and BiCl3. Synthetic Communications. 27(15). 2569–2576. 7 indexed citations
19.
Ren, Pingda, et al.. (1997). Reduction of Nitroarenes to N-Arylhydroxylamines with KBH4/BiCl3 System. Synthetic Communications. 27(20). 3497–3503. 24 indexed citations
20.
Ren, Pingda, et al.. (1996). Catalytic Reduction of Nitroarenes to Azoxybenzenes With Sodium Borohydride in the Presence of Bismuth. Synthetic Communications. 26(21). 3903–3908. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026